<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01601301</url>
  </required_header>
  <id_info>
    <org_study_id>PR0035</org_study_id>
    <nct_id>NCT01601301</nct_id>
  </id_info>
  <brief_title>Post-Market Study of the Ellipse PRECICE Intramedullary Limb Lengthening System</brief_title>
  <acronym>PINS</acronym>
  <official_title>A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ellipse Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ellipse Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain post market performance and safety data of the Ellipse
      PRECICE Intramedullary Limb Lengthening System for subjects undergoing unilateral limb
      lengthening.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subject data will be reviewed at the following visits:

        -  Preoperative

        -  Operative

        -  Every 7 to 14 days through Distraction Phase

        -  Every 4 to 6 weeks through Consolidation Phase

        -  6-Month Post-Consolidation

        -  12-Month Post-Consolidation

        -  18-Month Post-Consolidation

        -  24-Month Post-Consolidation
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distraction Control: actual distraction rate vs. target distraction rate</measure>
    <time_frame>Postoperatively, every 7-10 days up until the subject's distraction regimen is complete, an expected average of 33 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Union</measure>
    <time_frame>Following completion of the subject's distraction regimen, every 4-6 weeks until the subject's treated limb is evaluated as consolidated, an expected average of 66 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Up to 24 months post-consolidation of the treated limb, an expected total average of 29 months</time_frame>
    <description>Pain measured by the SF-36v2, American Academy of Orthopaedic Surgeons Lower Limb Outcomes Questionnaire, and medication use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing Index</measure>
    <time_frame>Up to 24 months post-consolidation of the treated limb, an expected total average of 29 months</time_frame>
    <description>The total treatment period with the PRECICE System in situ, divided by the length of bone growth in centimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days to complete lengthening</measure>
    <time_frame>Postoperatively, every 7-10 days up until the subject's distraction regimen is complete, an expected average of 33 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days to complete full weight bearing</measure>
    <time_frame>Up to an expected average of 99 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days to full consolidation</measure>
    <time_frame>Following completion of the subject's distraction regimen, every 4-6 weeks until the subject's treated limb is evaluated as consolidated, an expected average of 66 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Up to 24 months post-consolidation of the treated limb, an expected total average of 29 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device-related complications</measure>
    <time_frame>Up to 24 months post-consolidation of the treated limb, an expected total average of 29 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure-related complications</measure>
    <time_frame>Up to 24 months post-consolidation of the treated limb, an expected total average of 29 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Limb Length Discrepancy</condition>
  <arm_group>
    <arm_group_label>PRECICE System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PRECICE System</intervention_name>
    <description>Lenthening of either the tibia or femur with the PRECICE System.</description>
    <arm_group_label>PRECICE System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Leg length discrepancy ≥ 1.5 cm and ≤ 6.5 cm due to short femur or tibia

          -  Weight ≤ 114 kg if implanted with the 10.7 mm or 12.5 mm diameter nail, or ≤ 57 kg if
             implanted with the 8.5 mm diameter nail

          -  Skeletally mature

          -  Intramedullary canal without offset

          -  Tibia or femur sufficient to contain the implant

          -  Availability, willingness, and sufficient cognitive awareness to comply with protocol
             procedures and schedule

          -  Must sign informed consent to permit the use of personal health data

        Exclusion Criteria:

          -  Active infection or previous history of deep infection in the involved bone

          -  Metal allergies or sensitivities to the components of the device

          -  Distance from the nearest convenient external surface of the treated limb to the
             intramedullary canal &gt; 38 mm for the 8.5 mm PRECICE nail, &gt; 51 mm for the 10.7 mm
             PRECICE nail, or &gt; 76 mm for the 12.5 mm PRECICE nail

          -  Significant range of motion deficit of the adjacent joints

          -  Patients with a pacemaker, implanted cardiac defibrillator, or any other electronic or
             magnetic implant

          -  Patients who require an MRI during implantation

          -  Non-union

          -  Impassable or obstructed intramedullary canal

          -  Significant angular deformity that prevents device placement

          -  Cannot bear weight on the contralateral limb

          -  Procedural osteotomy cannot be made in an appropriate location

          -  Deformities that require multilevel osteotomies or bi-lateral implantation at the time
             of study index surgery

          -  Systemic bone disease

          -  Pregnant or nursing women

          -  Inadequate vascularity or evidence of vascular disease or peripheral neuropathy

          -  Malignancies or tumors in the involved bone

          -  Patient is a drug abuser

          -  Open wounds or ulcers that could compromise treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart A Green, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paley Advanced Limb Lengthening Institute</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ellipse-tech.com</url>
    <description>Ellipse Technologies Website</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2012</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Limb</keyword>
  <keyword>Lengthening</keyword>
  <keyword>PRECICE</keyword>
  <keyword>Ellipse</keyword>
  <keyword>Technologies</keyword>
  <keyword>Distraction</keyword>
  <keyword>Osteogenesis</keyword>
  <keyword>Femur</keyword>
  <keyword>Tibia</keyword>
  <keyword>Intramedullary</keyword>
  <keyword>Nail</keyword>
  <keyword>Device</keyword>
  <keyword>Medical</keyword>
  <keyword>Orthopedic</keyword>
  <keyword>Implant</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

